• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

益生菌治疗可改善帕金森病啮齿动物模型中依赖海马体的认知功能。

Probiotics Treatment Improves Hippocampal Dependent Cognition in a Rodent Model of Parkinson's Disease.

作者信息

Xie Caroline, Prasad Asheeta A

机构信息

School of Psychology, UNSW Sydney, Sydney NSW 2052, Australia.

出版信息

Microorganisms. 2020 Oct 27;8(11):1661. doi: 10.3390/microorganisms8111661.

DOI:10.3390/microorganisms8111661
PMID:33120961
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7692862/
Abstract

Parkinson's disease (PD) is a neurological disorder with motor dysfunction and a number of psychiatric symptoms. Symptoms such as anxiety and cognitive deficits emerge prior to motor symptoms and persist over time. There are limited treatments targeting PD psychiatric symptoms. Emerging studies reveal that the gut microbe is altered in PD patients. Here we assessed the effect of a probiotic treatment in a rat model of PD. We used the neurotoxin (6-hydroxydopamine, 6-OHDA) in a preclinical PD model to examine the impact of a probiotic treatment ( HA-114) on anxiety and memory. Rats underwent either sham surgery or received 6-OHDA bilaterally into the striatum. Three weeks post-surgery, rats were divided into three experimental groups: a sham group that received probiotics, a 6-OHDA group that received probiotics, and the third group of 6-OHDA received the placebo formula. All rats had access to either placebo or probiotics formula for 6 weeks. All groups were assessed for anxiety-like behaviour using the elevated plus maze. Cognition was assessed for both non-hippocampal and hippocampal dependent tasks using the novel object recognition and novel place recognition. We report that the 6-OHDA lesion induced anxiety-like behaviour and deficits in hippocampal dependent cognition. Interestingly, the probiotics treatment had no impact on anxiety-like behaviour but selectively improved hippocampal dependent cognition deficits. Together, the results presented here highlight the utility of animal models in examining the neuropsychiatric symptoms of PD and the potential of probiotics as adjunctive treatment for non-motor symptoms of PD.

摘要

帕金森病(PD)是一种伴有运动功能障碍和多种精神症状的神经疾病。焦虑和认知缺陷等症状在运动症状之前出现,并会持续存在。针对帕金森病精神症状的治疗方法有限。新出现的研究表明,帕金森病患者的肠道微生物发生了改变。在此,我们评估了益生菌治疗对帕金森病大鼠模型的影响。我们在临床前帕金森病模型中使用神经毒素(6-羟基多巴胺,6-OHDA)来研究益生菌治疗(HA-114)对焦虑和记忆的影响。大鼠要么接受假手术,要么双侧纹状体内注射6-OHDA。手术后三周,大鼠被分为三个实验组:接受益生菌的假手术组、接受益生菌的6-OHDA组以及接受安慰剂配方的第三组6-OHDA。所有大鼠均可在6周内获取安慰剂或益生菌配方。使用高架十字迷宫评估所有组的焦虑样行为。使用新物体识别和新位置识别对非海马体和海马体依赖性任务的认知进行评估。我们报告称,6-OHDA损伤诱发了焦虑样行为以及海马体依赖性认知缺陷。有趣的是,益生菌治疗对焦虑样行为没有影响,但选择性地改善了海马体依赖性认知缺陷。总之,此处呈现的结果凸显了动物模型在研究帕金森病神经精神症状方面的效用,以及益生菌作为帕金森病非运动症状辅助治疗的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/483f/7692862/42f7f86953dd/microorganisms-08-01661-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/483f/7692862/4a6bf87c8053/microorganisms-08-01661-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/483f/7692862/42f7f86953dd/microorganisms-08-01661-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/483f/7692862/4a6bf87c8053/microorganisms-08-01661-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/483f/7692862/42f7f86953dd/microorganisms-08-01661-g002.jpg

相似文献

1
Probiotics Treatment Improves Hippocampal Dependent Cognition in a Rodent Model of Parkinson's Disease.益生菌治疗可改善帕金森病啮齿动物模型中依赖海马体的认知功能。
Microorganisms. 2020 Oct 27;8(11):1661. doi: 10.3390/microorganisms8111661.
2
Limitations of the rat medial forebrain lesion model to study prefrontal cortex mediated cognitive tasks in Parkinson's disease.大鼠内侧前脑损伤模型在研究帕金森病前额叶皮层介导的认知任务中的局限性。
Brain Res. 2019 Jan 1;1702:105-113. doi: 10.1016/j.brainres.2018.03.035. Epub 2018 Mar 30.
3
Rodent models of Parkinson's disease: beyond the motor symptomatology.帕金森病的啮齿动物模型:超越运动症状学
Front Behav Neurosci. 2013 Nov 26;7:175. doi: 10.3389/fnbeh.2013.00175. eCollection 2013.
4
Post-lesion administration of 7-NI attenuated motor and non-motor deficits in 6-OHDA induced bilaterally lesioned female rat model of Parkinson's disease.在6-OHDA诱导的双侧损伤帕金森病雌性大鼠模型中,损伤后给予7-NI可减轻运动和非运动功能障碍。
Neurosci Lett. 2015 Mar 4;589:191-5. doi: 10.1016/j.neulet.2014.12.030. Epub 2014 Dec 17.
5
A Guide to the Generation of a 6-Hydroxydopamine Mouse Model of Parkinson's Disease for the Study of Non-Motor Symptoms.用于非运动症状研究的帕金森病6-羟基多巴胺小鼠模型构建指南
Biomedicines. 2021 May 25;9(6):598. doi: 10.3390/biomedicines9060598.
6
Activation and blockade of dorsal hippocampal Serotonin receptors regulate anxiety-like behaviors in a unilateral 6-hydroxydopamine rat model of Parkinson's disease.在帕金森病单侧6-羟基多巴胺大鼠模型中,背侧海马5-羟色胺受体的激活和阻断调节焦虑样行为。
Neurol Res. 2019 Sep;41(9):791-801. doi: 10.1080/01616412.2019.1611204. Epub 2019 May 6.
7
Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson's disease.抗生素引起的肠道微生物群改变可保护多巴胺神经元免受损失,并改善帕金森病药理模型中的运动缺陷。
Exp Neurol. 2020 Mar;325:113159. doi: 10.1016/j.expneurol.2019.113159. Epub 2019 Dec 13.
8
Implication of nigral dopaminergic lesion and repeated L-dopa exposure in neuropsychiatric symptoms of Parkinson's disease.黑质多巴胺能神经元损伤和反复左旋多巴暴露与帕金森病神经精神症状的关系。
Behav Brain Res. 2019 Mar 15;360:120-127. doi: 10.1016/j.bbr.2018.12.007. Epub 2018 Dec 3.
9
Altered adenosine 2A and dopamine D2 receptor availability in the 6-hydroxydopamine-treated rats with and without levodopa-induced dyskinesia.左旋多巴诱导异动症大鼠与无左旋多巴诱导异动症大鼠中,腺苷 A2A 和多巴胺 D2 受体可用性的改变。
Neuroimage. 2017 Aug 15;157:209-218. doi: 10.1016/j.neuroimage.2017.05.066. Epub 2017 Jun 2.
10
Golexanolone reduces glial activation in the striatum and improves non-motor and some motor alterations in a rat model of Parkinson's disease.戈利克沙诺龙可减轻帕金森病大鼠模型纹状体中的胶质细胞活化,并改善非运动和一些运动改变。
Front Aging Neurosci. 2024 Jun 21;16:1417938. doi: 10.3389/fnagi.2024.1417938. eCollection 2024.

引用本文的文献

1
Peroxisome Proliferator-Activated Receptors (PPARs) May Mediate the Neuroactive Effects of Probiotic Metabolites: An In Silico Approach.过氧化物酶体增殖物激活受体(PPARs)可能介导益生菌代谢产物的神经活性作用:一种计算机模拟方法
Int J Mol Sci. 2025 May 9;26(10):4507. doi: 10.3390/ijms26104507.
2
Challenges and Opportunities in Exploring Non-Motor Symptoms in 6-Hydroxydopamine Models of Parkinson's Disease: A Systematic Review.探索帕金森病6-羟基多巴胺模型中非运动症状的挑战与机遇:一项系统评价
J Neurochem. 2025 Feb;169(2):e70008. doi: 10.1111/jnc.70008.
3
Probiotics as Potential Treatments for Neurodegenerative Diseases: a Review of the Evidence from to Clinical Trial.

本文引用的文献

1
Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson Disease.肠道微生物组与帕金森病风险和前驱标志物的特征。
Ann Neurol. 2020 Aug;88(2):320-331. doi: 10.1002/ana.25788. Epub 2020 Jun 15.
2
Effects of the probiotic formulation SLAB51 in and Parkinson's disease models.SLAB51 益生菌配方对 和 帕金森病模型的影响。
Aging (Albany NY). 2020 Mar 9;12(5):4641-4659. doi: 10.18632/aging.102927.
3
Probiotic treatment improves the impaired spatial cognitive performance and restores synaptic plasticity in an animal model of Alzheimer's disease.
益生菌作为神经退行性疾病的潜在治疗方法:从基础研究到临床试验的证据综述
Biomol Ther (Seoul). 2025 Jan 1;33(1):54-74. doi: 10.4062/biomolther.2024.215. Epub 2024 Dec 16.
4
Advice to People with Parkinson's in My Clinic: Probiotics and Prebiotics.我的诊所给帕金森病患者的建议:益生菌和益生元。
J Parkinsons Dis. 2024;14(7):1507-1518. doi: 10.3233/JPD-240172.
5
Gut-directed therapy in Parkinson's disease.帕金森病的肠道定向治疗。
Front Pharmacol. 2024 Jun 21;15:1407925. doi: 10.3389/fphar.2024.1407925. eCollection 2024.
6
A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson's disease.鼠李糖乳杆菌 E9 对 MPTP 诱导的帕金森病模型小鼠肠道微生物群和肠道屏障的神经治疗作用。
Sci Rep. 2024 Jul 4;14(1):15460. doi: 10.1038/s41598-024-65061-w.
7
The gastrointestinal tract and Parkinson's disease.胃肠道与帕金森病
Front Cell Infect Microbiol. 2024 Jan 15;13:1158986. doi: 10.3389/fcimb.2023.1158986. eCollection 2023.
8
Gut Microbial Metabolome and Dysbiosis in Neurodegenerative Diseases: Psychobiotics and Fecal Microbiota Transplantation as a Therapeutic Approach-A Comprehensive Narrative Review.肠道微生物代谢组学与神经退行性疾病中的菌群失调:益生菌和粪便微生物群移植作为一种治疗方法——全面的叙述性综述。
Int J Mol Sci. 2023 Aug 27;24(17):13294. doi: 10.3390/ijms241713294.
9
Fatty acids derived from the probiotic Lacticaseibacillus rhamnosus HA-114 suppress age-dependent neurodegeneration.来源于益生菌鼠李糖乳杆菌 HA-114 的脂肪酸可抑制与年龄相关的神经退行性病变。
Commun Biol. 2022 Dec 7;5(1):1340. doi: 10.1038/s42003-022-04295-8.
10
CHCHD2 p.Thr61Ile knock-in mice exhibit motor defects and neuropathological features of Parkinson's disease.CHCHD2 p.Thr61Ile 敲入小鼠表现出运动缺陷和帕金森病的神经病理学特征。
Brain Pathol. 2023 May;33(3):e13124. doi: 10.1111/bpa.13124. Epub 2022 Nov 2.
益生菌治疗可改善阿尔茨海默病动物模型的受损空间认知能力,并恢复其突触可塑性。
Behav Brain Res. 2019 Dec 30;376:112183. doi: 10.1016/j.bbr.2019.112183. Epub 2019 Aug 28.
4
Altered Gut Microbiome in Parkinson's Disease and the Influence of Lipopolysaccharide in a Human α-Synuclein Over-Expressing Mouse Model.帕金森病中肠道微生物群的改变以及脂多糖在人α-突触核蛋白过表达小鼠模型中的影响
Front Neurosci. 2019 Aug 7;13:839. doi: 10.3389/fnins.2019.00839. eCollection 2019.
5
Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression.帕金森病中的肠道微生物群:时间稳定性及其与疾病进展的关系。
EBioMedicine. 2019 Jun;44:691-707. doi: 10.1016/j.ebiom.2019.05.064. Epub 2019 Jun 18.
6
Dysbiosis of gut microbiota in a selected population of Parkinson's patients.特定帕金森病患者人群的肠道微生物失调。
Parkinsonism Relat Disord. 2019 Aug;65:124-130. doi: 10.1016/j.parkreldis.2019.06.003. Epub 2019 Jun 3.
7
The gut microbiome regulates the increases in depressive-type behaviors and in inflammatory processes in the ventral hippocampus of stress vulnerable rats.肠道微生物群调节应激易感性大鼠腹侧海马中抑郁样行为和炎症过程的增加。
Mol Psychiatry. 2020 May;25(5):1068-1079. doi: 10.1038/s41380-019-0380-x. Epub 2019 Mar 4.
8
Mechanisms of Action of Probiotics.益生菌的作用机制。
Adv Nutr. 2019 Jan 1;10(suppl_1):S49-S66. doi: 10.1093/advances/nmy063.
9
The Gut-Brain Axis and the Microbiome: Mechanisms and Clinical Implications.肠-脑轴与微生物组:机制与临床意义。
Clin Gastroenterol Hepatol. 2019 Jan;17(2):322-332. doi: 10.1016/j.cgh.2018.10.002. Epub 2018 Oct 4.
10
Assessment and Management of Neuropsychiatric Symptoms in Parkinson's Disease.帕金森病神经精神症状的评估与管理。
CNS Drugs. 2018 Jul;32(7):621-635. doi: 10.1007/s40263-018-0540-6.